Catia Proenca, PhD

Catia designs and manages Real-World Evidence strategies maintaining a Market Access perspective by ensuring key stakeholder needs (e.g., HTA, payers) are met, thus, maximizing access to innovation, and ultimately improving patient outcomes. With 13+ years of experience in industry and academia, Catia’s previous roles include positions at Wellmera, Novartis Global, and the Novartis Institute for Biomedical Research. Catia holds a PhD in Neuroscience from the Weill Cornell Medical College, New York, and the University of Lisbon.